Acadia Pharmaceuticals
ACAD
ACAD
331 hedge funds and large institutions have $3.58B invested in Acadia Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 125 increasing their positions, 105 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% more funds holding
Funds holding: 308 → 331 (+23)
2% less capital invested
Capital invested by funds: $3.66B → $3.58B (-$83.6M)
2.06% less ownership
Funds ownership: 101.44% → 99.39% (-2.1%)
Holders
331
Holding in Top 10
5
Calls
$34.2M
Puts
$26.1M
Top Buyers
| 1 | +$56.3M | |
| 2 | +$44.5M | |
| 3 | +$33.4M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$31M |
| 5 |
State Street
Boston,
Massachusetts
|
+$25.5M |
Top Sellers
| 1 | -$69.1M | |
| 2 | -$63.6M | |
| 3 | -$43.8M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$39.9M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$39.8M |
